OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
October 29, 2020
Mogrify’s new technology platform, EpiMOGRIFY, can predict cellular switches important for determining cell identity, cell maintenance, directed differentiation, and cell conversion.
October 16, 2020
The new VirusExpress lentiviral production platform increases dose yields and reduces process development time for cell and gene therapies.
October 02, 2020
Bioreactor technology advances can offer seamless manufacturing scale-up and can reduce the timeline and cost of biologics production.
September 14, 2020
The investment will include new manufacturing lines and increased automation to deliver additional manufacturing capacity.
August 13, 2020
The company has made several moves in recent weeks to expand manufacturing capacity and cell line services.
July 02, 2020
Innovative approaches, including ready-to-use materials and in-line dilution, can significantly streamline overall bioprocessing operations.
June 01, 2020
Advanced data analytics, including statistical modeling and machine learning technique, can enable more efficient and reliable bioprocesses.
March 02, 2020
Better understanding and control of cell behavior is yielding benefits, upstream and beyond.
The future of raw material sourcing for mAb production may lay in the sustainability of the source and the added benefits of newer technologies.
February 01, 2020
The production of viral vectors for use in gene therapy benefits from being able to use similar cell-culture processes as mAbs, but it faces limitations under current cell-culture technologies.